C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
12/2001
12/05/2001	CN1324618A Pharmaceutical use of benzoic acid derivatives
12/05/2001	CN1075722C Fungicidal compositions containing bifonazole
12/04/2001	US6326500 Imidazole derivatives for blocking the release of arachidonic acid from phospholipids
12/04/2001	US6326398 Oxamic acids and derivatives as thyroid receptor ligands
12/04/2001	CA2098301C Certain aminomethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands
12/04/2001	CA2000553C Process for the preparation of 7-substituted-hept-6-enoic and -heptanoic acids and derivatives and intermediates thereof
11/2001
11/30/2001	CA2348966A1 Ionic liquids
11/29/2001	WO2001090113A1 Hydroxylamine esters as polymerization initiators
11/29/2001	WO2000040210A3 Topical compositions comprising protected functional thiols
11/29/2001	WO2000034258A3 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
11/29/2001	US20010047100 Derivatives of 2-(4-imidazolyl)cyclopropane as optically active H3 histamine receptor antagonists; CNS nervous disorders; sleeping and eating disorders; cardiotonic agents; Alzheimer's disease; cognition activators
11/29/2001	EP1143916A3 Topical compositions comprising protected functional thiols
11/28/2001	EP1157991A2 Herbicidal imidazolidinetrione and thioxo-imidazolidinediones
11/28/2001	EP1157985A1 Para- substituted phenylene derivatives and their use as integrin antagonists
11/28/2001	EP1157001A1 Oxamic acids and derivatives as thyroid receptor ligands
11/28/2001	EP1156804A1 Thrombopoietin mimetics
11/28/2001	EP0918745B1 Catalytic preparation process of n-acylglycine derivatives
11/28/2001	EP0770068B1 Conformationally rigid bicyclic and adamantane derivatives useful as alpha 2-adrenergic blocking agents
11/28/2001	CN1323787A Second order non-linear optical active imidazole molecules and their synthesis
11/28/2001	CN1075490C O-benzyl oxime ether derivatives and their use in crop production compositions
11/27/2001	US6323230 Epicuaneous route in the case of dermatological illnesses like psoriasis, atopic dermatitis and other similar affections, or when administered by oral or rectal route in the case of diseases of the epithelia of the lower intestines
11/27/2001	US6323225 Pharmaceutical composition
11/27/2001	US6323211 Alpha.-adrenergic receptor antagonist and at least one compound that elevates endogenous nitric oxide or endothelium-derived relaxing factor in vivo
11/27/2001	CA2197443C Quarternary substituted bleach activators
11/27/2001	CA2041835C Cyclohexenone oxime ethers, their preparation and their use as herbicides
11/22/2001	WO2001088160A2 Vectors for dna delivery
11/22/2001	WO2001087866A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	WO2001087849A2 Modulators of tnf- alpha signaling
11/22/2001	WO2001087848A2 Synthesis procedure for biphenylimidazolyl-(1)-phenylmethane and related compounds
11/22/2001	WO2001087840A1 Propanoic acid derivatives as integrin receptor antagonists
11/22/2001	WO2001087830A2 Substituted thioacetamides
11/22/2001	WO2001087828A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
11/22/2001	WO2001087819A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE α-AMINO ACID AND OPTICALLY ACTIVE α-AMINO ACID AMIDE
11/22/2001	WO2001087300A1 Creatinine biosensor
11/22/2001	WO2001087299A1 Aralkyl ester soft drugs
11/22/2001	WO2001066527A8 Substituted benzoylcyclohexenones
11/22/2001	WO2000056681A9 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction
11/22/2001	US20010044544 Useful as high energy oxidizing agents in explosive and propellant formulations, and drugs for vasodilation
11/22/2001	US20010044537 Inhibit human factor Xa; treating thrombotic activity; 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4-((2-(1,2 -dihydoxyethyl)-4-hydroxy-5-ethoxytetrahydrofuran-3-yl)oxy)-pyridin-2 -yl)oxy)4-hydroxybenzamidine
11/22/2001	US20010044536 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
11/22/2001	US20010044457 2-amino-1-benzylidenamino-4-phenylimidazoles
11/22/2001	US20010044456 Non-systemic control of parasites
11/22/2001	CA2781858A1 Modulators of tnf-.alpha. signaling
11/22/2001	CA2410077A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	CA2409116A1 Substituted thioacetamides
11/22/2001	CA2408885A1 Vectors for dna delivery
11/22/2001	CA2408408A1 Modulators of tnf- alpha signaling
11/22/2001	CA2407099A1 Aralkyl ester soft drugs
11/21/2001	EP1155026A2 Method for isolating nucleic acids
11/21/2001	EP1155025A1 Platinum (ii) compounds
11/21/2001	EP1155010A1 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s
11/21/2001	EP1154993A1 Thioamide derivatives
11/21/2001	EP1154992A1 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production
11/21/2001	EP1154987A1 Phenylalaninol derivatives
11/21/2001	EP1154983A1 Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
11/21/2001	EP0914319B1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/21/2001	EP0831910B1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
11/21/2001	EP0775117B1 Fluorinated 2-nitroimidazole analogs for detecting hypoxic tumor cells
11/21/2001	CN1323396A Endogenous constitutively activated G protein-coupled orphan receptors
11/21/2001	CN1323302A N-cimidazolylalkyl) substituted cyclic amines as histamine-H3 agonists or antagonists
11/21/2001	CN1323203A FC receptor modulators and uses thereof
11/21/2001	CN1322526A Compound for treating female sexual dysfunction
11/20/2001	US6320057 Reacting 2-thiothiazolidine-5-ones with an optionally acylated aryl- or heteroaryl-hydrazine
11/20/2001	US6320055 Process for preparing hydantoins or cyclic anhydrides of an amino acid
11/20/2001	US6320050 2-substituted phenyl-3-cycloalkyl substituted n-heteroaromatic propionamides; used to increase insulin secretion in the treatment of type ii diabetes.
11/20/2001	US6320047 Substituted aryl or heteroarylamides having retinoid-like biological activity
11/20/2001	US6319948 Retinoid antagonists and uses thereof
11/20/2001	US6319940 Carbanilides used as pesticides
11/20/2001	US6319939 Retinoic acid mimetic anlides
11/20/2001	US6319935 Used in treatment of elevated intraocular pressure, non insulin-dependent diabetes, male impotence and obesity
11/20/2001	US6319925 O-benzyl oxime ether derivatives and their use in crop protection compositions
11/20/2001	US6319428 Perfluorinated amide salts and their uses as ionic conducting materials
11/15/2001	WO2001085723A1 Gastrin and cholecystokinin receptor ligands (ii)
11/15/2001	WO2001085698A1 New polycyclic indanylimidazoles with alpha2 adrenergic activity
11/15/2001	WO2001085684A1 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide
11/15/2001	WO2001085170A1 Peptide deformylase inhibitors
11/15/2001	WO2001057043A8 Method for producing sulfonyl imidazole derivatives by phase transfer catalysis
11/15/2001	WO2001016150A3 Nucleoside analogues
11/15/2001	US20010041801 Prevent human retroviral reproduction, infections
11/15/2001	US20010041799 Diephenyl carbocyclic thioamide derivatives
11/15/2001	US20010041730 (1S,2S)-2-(2-(N-((3-benzoimidazol-2-yl)propyl)-N-methylamino)ethyl)-6 -fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl cyclopropanecarboxylate, for example; treating vascular disease such as gangrene, retinopathy, nephropathy
11/15/2001	US20010041726 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/15/2001	US20010041725 Novel urea derivatives having nitrogen aromatic heterocycle
11/15/2001	US20010041723 Using agonists and antagonists of the nicotinergic acetylcholine receptors of insects such as fleas, lice and flies, on humans and animals
11/15/2001	US20010041710 (4R)-1-(4-(4-Fluorophenoxy)benzyl)-2-oxo-imidazolidine-4 -carboxylic acid hydroxyamide, for example; treating various diseases including osteoarthritis, rheumatoid arthritis, cancer, osteoporosis, strokes
11/15/2001	US20010041700 A carbamoyl or S=C(NH) group containing nitrile derivatives, useful as cysteine protease inhibitor
11/15/2001	CA2408290A1 New polycyclic indanylimidazoles with alpha2 adrenergic activity
11/15/2001	CA2408236A1 Peptide deformylase inhibitors
11/14/2001	EP1153921A2 Cyclic ureas and analogues useful as retroviral protease inhibitors
11/14/2001	EP1153050A1 Amino-ketone solid support templates
11/14/2001	EP1153006A1 Stabilised compositions of o- and n-vinyl compounds and the use of ammonium salts as stabilisers
11/14/2001	EP0956016A4 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
11/14/2001	CN1322194A Substituted phenyl derivatives, their preparation and use
11/13/2001	US6316636 Synthesis of fluorocarbon compounds
11/13/2001	US6316478 IL-8 receptor antagonists
11/13/2001	US6316451 Heterocyclyl anthracyclinone derivatives
11/08/2001	WO2001083475A1 Novel heterocyclic compounds with anti-inflammatory activity
11/08/2001	WO2001083465A2 Alkynyl phenyl heteroaromatic glucokinase activators
11/08/2001	WO2001083423A2 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof
11/08/2001	WO2001041760A3 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect

1 ... 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 ... 345